ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,731,532 | -11.4% | 63,800 | +0.3% | 0.02% | -7.4% |
| Q2 2023 | $1,955,064 | -18.2% | 63,600 | -4.1% | 0.03% | -22.9% |
| Q1 2023 | $2,388,789 | -8.8% | 66,300 | 0.0% | 0.04% | -16.7% |
| Q4 2022 | $2,620,176 | -0.7% | 66,300 | +0.9% | 0.04% | -4.5% |
| Q3 2022 | $2,639,000 | -4.1% | 65,700 | +0.3% | 0.04% | 0.0% |
| Q2 2022 | $2,753,000 | +21.9% | 65,500 | +12.9% | 0.04% | +46.7% |
| Q1 2022 | $2,259,000 | -3.9% | 58,000 | -1.7% | 0.03% | +3.4% |
| Q4 2021 | $2,351,000 | +10.6% | 59,000 | +0.3% | 0.03% | 0.0% |
| Q3 2021 | $2,125,000 | -15.8% | 58,800 | -4.5% | 0.03% | -12.1% |
| Q2 2021 | $2,525,000 | -5.7% | 61,600 | +0.3% | 0.03% | -10.8% |
| Q1 2021 | $2,678,000 | +153.6% | 61,400 | +191.0% | 0.04% | +146.7% |
| Q4 2020 | $1,056,000 | – | 21,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |